• Teens with heart disease improve exercise capacity in large clinical trial

    21 days ago - By ScienceDaily

    The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in the care of those who have undergone the Fontan procedure, a palliative operation for single-ventricle disease.
    Read more ...

     

  • Exercise Capacity Enhanced in A Clinical Trial Among Teens With Heart Disease

    Exercise Capacity Enhanced in A Clinical Trial Among Teens With Heart Disease

    22 days ago - By Medindia Health

    Children's Hospital of philadelphia cardiologists report milestone results for Fontan survivors in multicenter, phase 3 FUEL Trial.
    Read more ...